This study tested a new booster vaccine called Covigenix VAX-002 in 46 healthy adults aged 18 and older. The vaccine uses DNA technology to target newer Omicron variants of the virus that causes COVID-19. The goal was to check if the booster is safe and helps the body build a str…
Phase: PHASE1, PHASE2 • Sponsor: Entos Pharmaceuticals Inc. • Aim: ⭐️ VACCINE ⭐️
Last updated May 14, 2026 12:04 UTC